General Archive

Home » Ventures funding » Page 2
  • News releases, Ventures funding

    LifeArc co-leads £6 million funding in DJS Antibodies

    LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the development of novel…

    Read more

  • News releases, Ventures funding

    LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics

    Funding to help drive the development of new cancer therapies

    Read more

  • News releases, Ventures funding

    LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases

    Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories

    Read more

  • Basophil, a white blood cell, 3D illustration. Basophils are granulocytes taking part in inflammatory reactions and allergic diseases - Illustration
    News releases, Ventures funding

    LifeArc invests £1.5 million in Ducentis BioTherapeutics

    LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease

    Read more